Search Results for 'gsk'

gsk published presentations and documents on DocSlides.

by roland

WashU Consultants. Lei Song. -. JD/MBA candidate. ...

Requisitioning a resolution at a GSK Annual General Meeting

Requisitioning a resolution at a GSK Annual General Meeting

by karlyn-bohler

Requisitioning a resolution. There are occasions ...

Introduction of GSK

Introduction of GSK

by marcus

One of the leading company in Pharmaceutical Indus...

First study of repeat dose

First study of repeat dose

by pamella-moone

co-administration of GSK1265744 . and TMC278 long...

44805 325300257025UZTIOR8ORKU3MKTJGYKSUW5GXKU64800333122OXNY

44805 325300257025UZTIOR8ORKU3MKTJGYKSUW5GXKU64800333122OXNY

by bery

6GYK4544805/- 325-300257--/025UZTIOR8ORKU3MKTJGYKS...

In particular GSKs attempt at intimidation appears to have been trig

In particular GSKs attempt at intimidation appears to have been trig

by phoebe

FDA,

Erfaringer fra HBV fusjon

Erfaringer fra HBV fusjon

by rozelle

Og . litt. . fra. . pågående. . fusjon. . me...

Årsrapporten 2017 Välkomna till UKÄ:s frukostseminarium!

Årsrapporten 2017 Välkomna till UKÄ:s frukostseminarium!

by danika-pritchard

#. trenderihögskolan. Agenda. Utbildning på gru...

Dual Specificity Mitogen-activated Protein Kinase Kinase 2

Dual Specificity Mitogen-activated Protein Kinase Kinase 2

by tatyana-admore

Kinections. Map P36507. MEK2/MAP2K2. P36507. -T2...

Hantering av examensarbeten

Hantering av examensarbeten

by alida-meadow

Kommentarmaterial med exempel. Michel Thomsen, Ma...

Whiteboards at a former GSK site: A good argument for using

Whiteboards at a former GSK site: A good argument for using

by luanne-stotts

Sean . Ekins. Summary. Oct 20 2012 - Triangle Mod...

SHP – oppsummering fra siste

SHP – oppsummering fra siste

by faustina-dinatale

utlysningsrunde. - 2012. . . Januar 2013. SH...

Popularisation of Science

Popularisation of Science

by marina-yarberry

Challenges and rewards in science communication. ...

Steve Davis President and CEO,

Steve Davis President and CEO,

by myesha-ticknor

PATH. May 19, 2016. PATH/Mark Murray. 6 billion v...

Steve Davis President and CEO,

Steve Davis President and CEO,

by natalia-silvester

PATH. May 19, 2016. PATH/Mark Murray. 6 billion v...

Artesunate for I njection

Artesunate for I njection

by yoshiko-marsland

Ipca. Rectal . artesunate. Strides . Pharma. Pyro...

Pavel Bostik FMHS Charles University Medical School

Pavel Bostik FMHS Charles University Medical School

by firingbarrels

University Hospital. Hradec Kralove. Czech Republi...

MolecularPsychiatry(1999)4,21

MolecularPsychiatry(1999)4,21

by evelyn

HYPOTHESIS Abimodalmodelofthemechanismofactionofli...

A Practical Approach toBEWE & Management ofErosive Tooth Wear in Pract

A Practical Approach toBEWE & Management ofErosive Tooth Wear in Pract

by claire

Supported by GSK the maker of Agenda 10.30WelcomeR...

Presented at the European Society for Medical Oncology 2019 Barcelona

Presented at the European Society for Medical Oncology 2019 Barcelona

by lucy

– 1 October, 2019 ● GSK 3377794 activate and i...

Vaccine Pricing

Vaccine Pricing

by violet

November 2018 | 1 Gavi Fully Self-financing & A...

Presented at the American Society of Clinical Oncology ASCO Annual Mee

Presented at the American Society of Clinical Oncology ASCO Annual Mee

by eliza

8 2021Patientswithhigh-doselymphodepletionCohort2w...

Tamar R. Grossman, PhD Antisense Oligonucleotide Therapy for Genetic Diseases

Tamar R. Grossman, PhD Antisense Oligonucleotide Therapy for Genetic Diseases

by quinn

Why Target RNA for Therapeutics?. RNA therapeutics...

MMV- supported projects

MMV- supported projects

by amber

Product development. Access. Patient. confirmatory...

Etiology-based drug discovery for Amyotrophic Lateral Sclerosis

Etiology-based drug discovery for Amyotrophic Lateral Sclerosis

by candy

Thomas J. Lukas, Ph.D.. Department of . Pharmacolo...

Treatment Use of Unlicensed Medicines

Treatment Use of Unlicensed Medicines

by gelbero

GS K Public P ol icy Position ...

Nicky Best (GSK), Aaron Dane (Danestat

Nicky Best (GSK), Aaron Dane (Danestat

by luanne-stotts

Nicky Best (GSK), Aaron Dane (Danestat Consulting)...

Time to Coagulation in Tubes

Time to Coagulation in Tubes

by celsa-spraggs

Due to the manufacturing process of adding the ED...

The Downside of Publication

The Downside of Publication

by liane-varnes

Group 2: Jing Kai, . Nabilah. and Soon Guan. Pre...

TuNGSTEN E-INVOICE SUBMISSION GUIDE

TuNGSTEN E-INVOICE SUBMISSION GUIDE

by trish-goza

OBJECTIVE. To give GSK more opportunity to pay yo...

Kim berley Hacquoil , Statistics, Programming and Data Strategy GSK

Kim berley Hacquoil , Statistics, Programming and Data Strategy GSK

by lindy-dunigan

Maria Costa. , Statistics, Programming and Data S...

Development of RSV Vaccines

Development of RSV Vaccines

by kittie-lecroy

Ann-Muriel . Steff. , PhD. Head, Preclinical Plat...

The Downside of Publication

The Downside of Publication

by karlyn-bohler

Group 2: Jing Kai, . Nabilah. and Soon Guan. Pre...

by lindy-dunigan

Song. , . Director, Anti-Monopoly Div., . KFTC. ...

Pharmaceutical TNCs

Pharmaceutical TNCs

by luanne-stotts

GlaxoSmithKline. Health matters in a globalising ...

by faustina-dinatale

Proposal . for. Asha. for Education, Austin Chap...

by natalia-silvester

, Virgil D. Gligor, and . Zongwei. Zhou. CyLab. ...

GSK - A MERGER TOO FAR? Bernardo B

GSK - A MERGER TOO FAR? Bernardo B

by pasty-toler

1 Pharmaceutical Executive, May 1999, p. 37 2 p...

ApproachtotheDiagnosisofInterstitialLungJ

ApproachtotheDiagnosisofInterstitialLungJ

by celsa-spraggs

Disclosures:J.B.hasreceivedfeesforspeakingfromActe...

Manifestation of Novel Social Challenges of the European Un

Manifestation of Novel Social Challenges of the European Un

by cheryl-pisano

in the Teaching Material of. Medical Biotechnolog...